Switch to:
Also traded in: Chile, Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.09
CVS's Cash to Debt is ranked lower than
89% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.57 vs. CVS: 0.09 )
Ranked among companies with meaningful Cash to Debt only.
CVS' s Cash to Debt Range Over the Past 10 Years
Min: 0.09  Med: 0.18 Max: 0.78
Current: 0.09
0.09
0.78
Equity to Asset 0.40
CVS's Equity to Asset is ranked higher than
57% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.35 vs. CVS: 0.40 )
Ranked among companies with meaningful Equity to Asset only.
CVS' s Equity to Asset Range Over the Past 10 Years
Min: 0.39  Med: 0.53 Max: 0.61
Current: 0.4
0.39
0.61
Interest Coverage 11.02
CVS's Interest Coverage is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.35 vs. CVS: 11.02 )
Ranked among companies with meaningful Interest Coverage only.
CVS' s Interest Coverage Range Over the Past 10 Years
Min: 10.77  Med: 11.43 Max: 15.55
Current: 11.02
10.77
15.55
F-Score: 7
Z-Score: 3.73
M-Score: -2.50
WACC vs ROIC
8.08%
10.67%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 6.17
CVS's Operating margin (%) is ranked higher than
71% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.11 vs. CVS: 6.17 )
Ranked among companies with meaningful Operating margin (%) only.
CVS' s Operating margin (%) Range Over the Past 10 Years
Min: 5.57  Med: 6.30 Max: 6.91
Current: 6.17
5.57
6.91
Net-margin (%) 3.42
CVS's Net-margin (%) is ranked higher than
71% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.12 vs. CVS: 3.42 )
Ranked among companies with meaningful Net-margin (%) only.
CVS' s Net-margin (%) Range Over the Past 10 Years
Min: 3.12  Med: 3.44 Max: 3.76
Current: 3.42
3.12
3.76
ROE (%) 14.04
CVS's ROE (%) is ranked higher than
69% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.89 vs. CVS: 14.04 )
Ranked among companies with meaningful ROE (%) only.
CVS' s ROE (%) Range Over the Past 10 Years
Min: 9.14  Med: 11.33 Max: 14.85
Current: 14.04
9.14
14.85
ROA (%) 6.41
CVS's ROA (%) is ranked higher than
86% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.73 vs. CVS: 6.41 )
Ranked among companies with meaningful ROA (%) only.
CVS' s ROA (%) Range Over the Past 10 Years
Min: 5.46  Med: 6.14 Max: 7.64
Current: 6.41
5.46
7.64
ROC (Joel Greenblatt) (%) 62.40
CVS's ROC (Joel Greenblatt) (%) is ranked lower than
54% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 86.38 vs. CVS: 62.40 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CVS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 26.8  Med: 47.33 Max: 62.63
Current: 62.4
26.8
62.63
Revenue Growth (3Y)(%) 12.30
CVS's Revenue Growth (3Y)(%) is ranked higher than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.30 vs. CVS: 12.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CVS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 7.7  Med: 12.30 Max: 16
Current: 12.3
7.7
16
EBITDA Growth (3Y)(%) 15.10
CVS's EBITDA Growth (3Y)(%) is ranked higher than
68% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. CVS: 15.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CVS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 2.4  Med: 14.20 Max: 44
Current: 15.1
2.4
44
EPS Growth (3Y)(%) 15.20
CVS's EPS Growth (3Y)(%) is ranked higher than
73% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.30 vs. CVS: 15.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CVS' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 1.7  Med: 15.20 Max: 112.8
Current: 15.2
1.7
112.8
» CVS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

CVS Guru Trades in Q1 2015

Richard Pzena 527,165 sh (New)
Caxton Associates 4,000 sh (New)
Joel Greenblatt 272,287 sh (+5183.02%)
Paul Tudor Jones 94,783 sh (+700.06%)
Jeremy Grantham 1,049,025 sh (+363.56%)
Manning & Napier Advisors, Inc 141,000 sh (+12.62%)
Ken Fisher 158,975 sh (+11.93%)
Tom Gayner 245,000 sh (+5.60%)
PRIMECAP Management 3,303,890 sh (+3.67%)
Charles de Vaulx 915,821 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Ruane Cunniff 24,953 sh (unchged)
Mairs and Power Sold Out
Ray Dalio Sold Out
Pioneer Investments 5,446,829 sh (-0.90%)
Jeff Auxier 95,999 sh (-1.84%)
Vanguard Health Care Fund 3,899,920 sh (-2.87%)
Mario Gabelli 1,438,163 sh (-3.43%)
RS Investment Management 478,044 sh (-3.77%)
Scott Black 100,312 sh (-7.23%)
NWQ Managers 1,173,665 sh (-8.83%)
John Rogers 84,095 sh (-10.23%)
James Barrow 304,950 sh (-13.61%)
Robert Olstein 57,000 sh (-24.00%)
Signature Select Canadian Fund 75,753 sh (-24.14%)
First Pacific Advisors 4,629,500 sh (-32.76%)
Steven Romick 4,146,600 sh (-33.33%)
» More
Q2 2015

CVS Guru Trades in Q2 2015

Louis Moore Bacon 50,000 sh (New)
Steven Cohen 34,300 sh (New)
Jeremy Grantham 2,058,725 sh (+96.25%)
RS Investment Management 681,410 sh (+42.54%)
James Barrow 389,950 sh (+27.87%)
PRIMECAP Management 3,602,710 sh (+9.04%)
Tom Gayner 247,000 sh (+0.82%)
Pioneer Investments 5,490,251 sh (+0.80%)
Richard Pzena 527,265 sh (+0.02%)
Robert Olstein 57,000 sh (unchged)
Steven Romick 4,146,600 sh (unchged)
Vanguard Health Care Fund 3,899,920 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Charles de Vaulx 915,821 sh (unchged)
Ruane Cunniff 24,953 sh (unchged)
Caxton Associates Sold Out
First Pacific Advisors 4,621,500 sh (-0.17%)
Jeff Auxier 95,649 sh (-0.36%)
Scott Black 99,462 sh (-0.85%)
John Rogers 82,895 sh (-1.43%)
Ken Fisher 156,437 sh (-1.60%)
Mario Gabelli 1,359,978 sh (-5.44%)
NWQ Managers 819,859 sh (-30.15%)
Manning & Napier Advisors, Inc 88,230 sh (-37.43%)
Joel Greenblatt 91,217 sh (-66.50%)
Paul Tudor Jones 3,200 sh (-96.62%)
» More
Q3 2015

CVS Guru Trades in Q3 2015

John Burbank 30,304 sh (New)
Mairs and Power 2,246 sh (New)
Jim Simons 854,505 sh (New)
Louis Moore Bacon 123,000 sh (+146.00%)
Jeremy Grantham 2,397,897 sh (+16.47%)
RS Investment Management 714,365 sh (+4.84%)
Ruane Cunniff 24,953 sh (unchged)
Richard Pzena 527,265 sh (unchged)
Tom Gayner 247,000 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
John Rogers Sold Out
Steven Cohen Sold Out
James Barrow 383,650 sh (-1.62%)
Manning & Napier Advisors, Inc 85,900 sh (-2.64%)
Signature Select Canadian Fund 72,453 sh (-4.36%)
NWQ Managers 783,473 sh (-4.44%)
PRIMECAP Management 3,408,820 sh (-5.38%)
Charles de Vaulx 840,664 sh (-8.21%)
Scott Black 89,505 sh (-10.01%)
Mario Gabelli 1,215,593 sh (-10.62%)
Pioneer Investments 4,893,987 sh (-10.86%)
Paul Tudor Jones 2,600 sh (-18.75%)
Vanguard Health Care Fund 3,084,020 sh (-20.92%)
Robert Olstein 45,000 sh (-21.05%)
Ken Fisher 122,805 sh (-21.50%)
Jeff Auxier 52,499 sh (-45.11%)
Joel Greenblatt 20,797 sh (-77.20%)
First Pacific Advisors 681,570 sh (-85.25%)
Steven Romick 507,110 sh (-87.77%)
» More
Q4 2015

CVS Guru Trades in Q4 2015

Ray Dalio 83,137 sh (New)
Robert Olstein 64,000 sh (+42.22%)
RS Investment Management 788,185 sh (+10.33%)
PRIMECAP Management 3,545,070 sh (+4.00%)
Pioneer Investments 5,082,510 sh (+3.85%)
Richard Pzena 527,389 sh (+0.02%)
Jeff Auxier 52,499 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Vanguard Health Care Fund 3,084,020 sh (unchged)
Jim Simons Sold Out
Steven Romick Sold Out
Ken Fisher 122,308 sh (-0.40%)
NWQ Managers 760,638 sh (-2.91%)
Mario Gabelli 1,178,788 sh (-3.03%)
James Barrow 368,897 sh (-3.85%)
Jeremy Grantham 2,300,997 sh (-4.04%)
» More
» Details

Insider Trades

Latest Guru Trades with CVS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on CVS Health Corp

Mario Gabelli Comments on CVS Health Corp - Feb 05, 2016

CVS Health Corp. (2.4%) (CVS – $97.77 – NYSE)(NYSE:CVS) is the leading pharmacy and pharmacy benefits manager in the country, with over $150 billion in annual revenue. The company’s recent acquisitions of institutional pharmacy Omnicare and the pharmacies inside Target stores should add $0.15 to earnings in 2016 and further CVS’s dominance across the pharmacy channel. Same store sales should improve in 2016 now that the company has annualized its decision to stop selling tobacco, and that decision has helped them win over $11 billion in net new business for its pharmacy benefits management (PBM) division.

From Mario Gabelli (Trades, Portfolio)'s GAMCO Equity Income Fund fourth quarter 2015 commentary.

Check out Mario Gabelli latest stock trades

Mario Gabelli Comments on CVS Health Corp - Mar 12, 2015

CVS Health Corp. (0.9%) (CVS – $96.31 – NYSE) is a pharmacy innovation company helping people on their path to better health. Through their 7,800 retail pharmacies, more than 900 walk-in medical clinics, a leading pharmacy benefits manager with nearly 65 million plan members, and expanding specialty pharmacy services, CVS Health enables people, businesses and communities to manage health in more affordable, effective ways. Their unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs.

From Mario Gabelli (Trades, Portfolio)’s Asset Fund Q4 2014 Commentary.

Check out Mario Gabelli latest stock trades

Mario Gabelli Comments on CVS Health Corp - Oct 29, 2014

CVS Health Corp. (1.6%) (CVS - $79.59 - NYSE) operates one of the largest retail pharmacy chains in the country, and the company is poised to benefit from the expansion of insurance coverage under healthcare reform with no new taxes or regulation. CVS is expanding into the fast growing market for specialty and biotech medicines, particularly through the recently announced $2 billion acquisition of home infusion provider Coram. CVS Health recently stopped selling tobacco in its stores, but the company is performing so strongly this year that it can easily absorb the $2 billion in lost sales. The company can sustain double digit earnings growth, and management continues to return a substantial amount of cash to shareholders via a higher dividend and share repurchases.

From Mario Gabelli (Trades, Portfolio)’s Equity Income Fund Q3 2014 Commentary.

Check out Mario Gabelli latest stock trades

Top Ranked Articles about CVS Health Corp

Mario Gabelli Comments on CVS Health Corp Guru stock highlight
CVS Health Corp. (2.4%) (CVS – $97.77 – NYSE)(NYSE:CVS) is the leading pharmacy and pharmacy benefits manager in the country, with over $150 billion in annual revenue. The company’s recent acquisitions of institutional pharmacy Omnicare and the pharmacies inside Target stores should add $0.15 to earnings in 2016 and further CVS’s dominance across the pharmacy channel. Same store sales should improve in 2016 now that the company has annualized its decision to stop selling tobacco, and that decision has helped them win over $11 billion in net new business for its pharmacy benefits management (PBM) division. Read more...
Steven Romick Sells Microsoft, Walgreens, CVS FPA portfolio manager trims Microsoft stake by 20%
Steven Romick (Trades, Portfolio) sold many stocks during the fourth quarter. He is the portfolio manager of the FPA Crescent Fund and the following are the most weighted sales during the last quarter of 2015. Read more...
First Pacific Advisors Slashes Stake in CVS Health Guru nearly triples stake in United Technologies, invests in stake in Esterline Technologies
First Pacific Advisors (Trades, Portfolio), a Los Angeles-based investment management firm, has a preference for stocks in the technology and financial services sectors, but its most eye-popping deal in the third quarter was the reduction of a stake in the health care sector. Read more...
Health Care Stocks Play Prominent Roles in Steven Romick's Transactions Guru reduces stakes in CVS Health, Express Scripts, Thermo Fisher in 3rd quarter
The health care sector occupies a low position in Steven Romick (Trades, Portfolio)’s sector weightings, but those companies were among his most prominent third-quarter trades. Read more...
Richard Pzena Makes 12 New Buys in First Quarter
Guru Richard Pzena (Trades, Portfolio), founder and co-chief investment officer of Pzena Investment Management, LLC, made both his reputation and his fortune by focusing on good companies selling at low prices. In the first quarter of 2015, the emphasis in Pzena’s 12 new buys was clearly on technology companies, energy stocks and financial services – but not exclusively. Read more...
Mario Gabelli Comments on CVS Health Corp
CVS Health Corp. (0.9%) (CVS – $96.31 – NYSE) is a pharmacy innovation company helping people on their path to better health. Through their 7,800 retail pharmacies, more than 900 walk-in medical clinics, a leading pharmacy benefits manager with nearly 65 million plan members, and expanding specialty pharmacy services, CVS Health enables people, businesses and communities to manage health in more affordable, effective ways. Their unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 21.60
CVS's P/E(ttm) is ranked lower than
66% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 18.24 vs. CVS: 21.60 )
Ranked among companies with meaningful P/E(ttm) only.
CVS' s P/E(ttm) Range Over the Past 10 Years
Min: 10.58  Med: 18.42 Max: 27.17
Current: 21.6
10.58
27.17
Forward P/E 14.90
CVS's Forward P/E is ranked lower than
69% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.97 vs. CVS: 14.90 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 21.60
CVS's PE(NRI) is ranked lower than
60% of the 30 Companies
in the Global Health Care Plans industry.

( Industry Median: 20.00 vs. CVS: 21.60 )
Ranked among companies with meaningful PE(NRI) only.
CVS' s PE(NRI) Range Over the Past 10 Years
Min: 10.62  Med: 18.45 Max: 27.17
Current: 21.6
10.62
27.17
P/B 2.84
CVS's P/B is ranked lower than
83% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.30 vs. CVS: 2.84 )
Ranked among companies with meaningful P/B only.
CVS' s P/B Range Over the Past 10 Years
Min: 1.01  Med: 1.78 Max: 3.38
Current: 2.84
1.01
3.38
P/S 0.73
CVS's P/S is ranked lower than
76% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.47 vs. CVS: 0.73 )
Ranked among companies with meaningful P/S only.
CVS' s P/S Range Over the Past 10 Years
Min: 0.4  Med: 0.62 Max: 0.89
Current: 0.73
0.4
0.89
PFCF 18.12
CVS's PFCF is ranked lower than
76% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.89 vs. CVS: 18.12 )
Ranked among companies with meaningful PFCF only.
CVS' s PFCF Range Over the Past 10 Years
Min: 9.13  Med: 22.05 Max: 208.79
Current: 18.12
9.13
208.79
POCF 13.28
CVS's POCF is ranked lower than
76% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.72 vs. CVS: 13.28 )
Ranked among companies with meaningful POCF only.
CVS' s POCF Range Over the Past 10 Years
Min: 6.73  Med: 13.82 Max: 35.82
Current: 13.28
6.73
35.82
EV-to-EBIT 14.37
CVS's EV-to-EBIT is ranked lower than
67% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.90 vs. CVS: 14.37 )
Ranked among companies with meaningful EV-to-EBIT only.
CVS' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.6  Med: 11.70 Max: 20.4
Current: 14.37
7.6
20.4
EV-to-EBITDA 11.77
CVS's EV-to-EBITDA is ranked lower than
73% of the 40 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.69 vs. CVS: 11.77 )
Ranked among companies with meaningful EV-to-EBITDA only.
CVS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.2  Med: 9.45 Max: 16
Current: 11.77
6.2
16
PEG 1.58
CVS's PEG is ranked lower than
57% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. CVS: 1.58 )
Ranked among companies with meaningful PEG only.
CVS' s PEG Range Over the Past 10 Years
Min: 0.56  Med: 1.44 Max: 3.8
Current: 1.58
0.56
3.8
Shiller P/E 32.41
CVS's Shiller P/E is ranked lower than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.70 vs. CVS: 32.41 )
Ranked among companies with meaningful Shiller P/E only.
CVS' s Shiller P/E Range Over the Past 10 Years
Min: 17.19  Med: 26.30 Max: 39.05
Current: 32.41
17.19
39.05
Current Ratio 1.31
CVS's Current Ratio is ranked higher than
65% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.23 vs. CVS: 1.31 )
Ranked among companies with meaningful Current Ratio only.
CVS' s Current Ratio Range Over the Past 10 Years
Min: 1.23  Med: 1.58 Max: 1.93
Current: 1.31
1.23
1.93
Quick Ratio 0.71
CVS's Quick Ratio is ranked lower than
65% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.12 vs. CVS: 0.71 )
Ranked among companies with meaningful Quick Ratio only.
CVS' s Quick Ratio Range Over the Past 10 Years
Min: 0.35  Med: 0.58 Max: 0.93
Current: 0.71
0.35
0.93
Days Inventory 36.76
CVS's Days Inventory is ranked lower than
82% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.26 vs. CVS: 36.76 )
Ranked among companies with meaningful Days Inventory only.
CVS' s Days Inventory Range Over the Past 10 Years
Min: 36.78  Med: 44.51 Max: 72.98
Current: 36.76
36.78
72.98
Days Sales Outstanding 28.31
CVS's Days Sales Outstanding is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 26.96 vs. CVS: 28.31 )
Ranked among companies with meaningful Days Sales Outstanding only.
CVS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.77  Med: 21.26 Max: 28.31
Current: 28.31
18.77
28.31
Days Payable 21.57
CVS's Days Payable is ranked lower than
69% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 49.48 vs. CVS: 21.57 )
Ranked among companies with meaningful Days Payable only.
CVS' s Days Payable Range Over the Past 10 Years
Min: 16.69  Med: 19.86 Max: 28.69
Current: 21.57
16.69
28.69

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.54
CVS's Dividend Yield is ranked lower than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.03 vs. CVS: 1.54 )
Ranked among companies with meaningful Dividend Yield only.
CVS' s Dividend Yield Range Over the Past 10 Years
Min: 0.42  Med: 1.04 Max: 1.47
Current: 1.54
0.42
1.47
Dividend Payout 0.30
CVS's Dividend Payout is ranked higher than
58% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.67 vs. CVS: 0.30 )
Ranked among companies with meaningful Dividend Payout only.
CVS' s Dividend Payout Range Over the Past 10 Years
Min: 0.1  Med: 0.14 Max: 1.16
Current: 0.3
0.1
1.16
Dividend Growth (3y) 29.10
CVS's Dividend Growth (3y) is ranked higher than
62% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 29.10 vs. CVS: 29.10 )
Ranked among companies with meaningful Dividend Growth (3y) only.
CVS' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -13.6  Med: 15.20 Max: 37
Current: 29.1
-13.6
37
Forward Dividend Yield 1.77
CVS's Forward Dividend Yield is ranked higher than
50% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.83 vs. CVS: 1.77 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 6.08
CVS's Yield on cost (5-Year) is ranked higher than
52% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.14 vs. CVS: 6.08 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CVS' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.66  Med: 4.10 Max: 6.08
Current: 6.08
1.66
6.08
3-Year Average Share Buyback Ratio 4.20
CVS's 3-Year Average Share Buyback Ratio is ranked higher than
91% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.60 vs. CVS: 4.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CVS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -20.4  Med: -0.40 Max: 4.6
Current: 4.2
-20.4
4.6

Valuation & Return

vs
industry
vs
history
Price/DCF (Earnings Based) 1.26
CVS's Price/DCF (Earnings Based) is ranked higher than
50% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.26 vs. CVS: 1.26 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Earnings Yield (Greenblatt) (%) 7.00
CVS's Earnings Yield (Greenblatt) (%) is ranked higher than
61% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.90 vs. CVS: 7.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CVS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.9  Med: 8.60 Max: 13.2
Current: 7
4.9
13.2
Forward Rate of Return (Yacktman) (%) 17.09
CVS's Forward Rate of Return (Yacktman) (%) is ranked higher than
56% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.97 vs. CVS: 17.09 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CVS' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 5.6  Med: 15.80 Max: 24.1
Current: 17.09
5.6
24.1

More Statistics

Revenue(Mil) $153290
EPS $ 4.64
Beta1.00
Short Percentage of Float1.38%
52-Week Range $81.37 - 113.65
Shares Outstanding(Mil)1098.49

Analyst Estimate

Dec16 Dec17 Dec18
Revenue(Mil) 133,223 129,428 206,820
EPS($) 5.79 6.44 7.23
EPS without NRI($) 5.79 6.44 7.23

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:SHDMF, APNHF, GNC, JCOUF, PMC » details
Traded in other countries:CVS.Chile, CVS.Germany, CVS.Mexico,
CVS Health Corp, formerly known as CVS Caremark Corporation was incorporated in the State of Delaware. The Company is an integrated pharmacy health care provider in the United States. They have three segments: Pharmacy Services, Retail Pharmacy and Corporate. The pharmacy services segment provides pharmacy benefit management services, as described more fully below, to their clients consisting primarily of employers, insurance companies, unions, government employee groups, managed care organizations ("MCOs") and other sponsors of health benefit plans and individuals throughout the United States. They operate a network of mail service specialty pharmacies. There specialty pharmacies were comprised of 11 specialty mail order pharmacies located throughout the United States that are used for delivery of medications to individuals with chronic or genetic diseases and disorders. The retail pharmacy segment included 7,660 retail drugstores, of which 7,603 operated a pharmacy, their online retail pharmacy websites, CVS.com and Onofre.com.br, 17 onsite pharmacy stores and retail health care clinics. There corporate segment provides management and administrative services to support the operations of the company. The corporate Segment consists of certain aspects of executive management, corporate relations, legal, compliance, human resources, corporate information technology and finance departments. Its customers include managed care organizations and government-funded health care commercial employers. It competes with other drugstore chains like Walgreens and Rite Aid, supermarkets, discount retailers (e.g., Wal-Mart and Target), independent pharmacies, restrictive pharmacy networks, membership clubs, Internet companies and retail health clinics, as well as other mail order pharmacies and PBMs. The Company's business is subject to federal and state laws and regulations that govern the purchase, sale and distribution of prescription drugs and related services, including administration and management of prescription drug benefits.
» More Articles for CVS

Headlines

Articles On GuruFocus.com
Mario Gabelli Comments on CVS Health Corp Feb 05 2016 
Steven Romick Sells Microsoft, Walgreens, CVS Jan 20 2016 
Louis Moore Bacon's Largest 3rd Quarter Trades Dec 23 2015 
First Pacific Advisors Slashes Stake in CVS Health Dec 17 2015 
Health Care Stocks Play Prominent Roles in Steven Romick's Transactions Dec 15 2015 
John Rogers Sells Position in CVS Dec 12 2015 
Taking a Look at Barron’s 10 Favorite Stocks for 2016 Dec 07 2015 
How the Walgreens-Rite Aid Deal Stacks Up Against Paulson's Merger Arbitrage Checklist Nov 05 2015 
Walgreens Buys Rite Aid to Avoid Loose Market Nov 04 2015 
How Rite Aid Deal Will Change Walgreens Oct 30 2015 

More From Other Websites
CVS HEALTH CORP Financials Feb 13 2016
How the quiet rise of beacons has reshaped retail marketing Feb 13 2016
Levi & Korsinsky Is Investigating Coty’s Fiduciary Duty Feb 13 2016
[$$] Core-Mark Stock Looks Vulnerable Feb 13 2016
Express Scripts sees slow 2016 sales for new cholesterol drugs Feb 12 2016
Here’s what CEOs said on this week’s earnings calls Feb 12 2016
Dorman: The state of tech investing and all things pharma... Feb 12 2016
CVS Earnings: Strong Performance Driven by Acquisitions and Growth In Specialty Business Feb 12 2016
Froedtert & the Medical College affiliation with CVS to coordinate patient care Feb 11 2016
CVS Health Corp. Earnings Analysis: 2015 By the Numbers Feb 11 2016
Target Two-Fer: Growth Stock, Solid Dividend Feb 11 2016
Cisco PT Raised; SolarCity Upgraded; Disney, CVS PTs Cut Feb 10 2016
US Stock Indices Fell: Why Did They Follow Oil Prices? Feb 10 2016
CVS Health Offering Meningitis Vaccines to Residents in Santa Clara County, CA Feb 10 2016
CVS Posts Healthy profit, Affirms 2016 Guidance (CVS) Feb 10 2016
CVS Health Company Accordant Earns NCQA Accreditation for Case Management Feb 10 2016
[$$] CVS Profit Grows on Higher Sales of Prescription Drugs Feb 10 2016
[$$] CVS Profit Grows, But Forecast Soft Feb 09 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK